Serial Number
98225243
Owner
Ionis Pharmaceuticals, Inc.Attorney
Brian FocarinoFirst Use Date
Dec 30, 2024
Filing Date
Oct 16, 2023
TRYNGOLZA Trademark
Serial Number: 98225243 • Registration: 7796631
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Brian Focarino Cooley LLP
1299 Pennsylvania Avenue, NW, Suite 700
IP Docketing Department
Washington, DC 20004-2400
United States
Trademark Details
Filing Date
October 16, 2023
Registration Date
May 13, 2025
First Use Anywhere
December 30, 2024
First Use in Commerce
December 30, 2024
Published for Opposition
July 16, 2024
Goods & Services
Medical services; medical information services; providing a website featuring medical and healthcare information for healthcare professionals, caregivers, patients, and providers in the field of genetic diseases and disorders; medical consulting services in the field of genetic diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of genetic diseases and disorders, and collecting data and information on genetic diseases and disorders for treatment and diagnostic purposes; providing medical and healthcare information concerning the screening, diagnosis, and treatment of genetic diseases and disorders; providing a website featuring medical and healthcare information for healthcare professionals, caregivers, patients, and providers in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; medical consulting services in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders, and collecting data and information on cardiovascular, metabolic, neurological and inflammatory diseases and disorders for treatment and diagnostic purposes; providing medical and healthcare information concerning the screening, diagnosis, and treatment of cardiovascular, metabolic, neurological and inflammatory diseases and disorders
